Lupus Landmark Study: A Prospective Registry and Biorepository

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorLupus Research Alliance

About this trial

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Able to understand and comply with study procedures and voluntarily sign a written informed consent document

Age 18 years or older at the time of enrollment

Disqualifiers

Not able to obtain consent

Not able to meet protocol visit requirements

Pregnant at the time of enrollment

Trial population

Patients with SLE

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

3,500 Participants
are grouped into 4 trial groups
Group A: New Onset
Group B: LN Active
Group C: Extra-renal Flare
Group D: Prevalent

Trial outcomes

Primary outcomes

1

Identify genetic drivers and antigenic targets, to elucidate mechanistic heterogeneity and correlate biomarkers to therapeutic responses.

Resource intended to be used to address research questions based upon three categorical time frames (historical, cross-sectional, and longitudinal) with specified scientific topics proposed upon request to access the resources.

Time frame
up to 25 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.